BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
Morgan Stanley downgrades Sun Pharma to equal weight
Halol warning letter will slow down US growth; stock could trade down and remain lacklustre for 6-9 months. Upcoming large launches can put floor under stock price. Earnings per share estimates cut by 10.5 per cent and 6.1 per cent for FY17 and FY18.